Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective

0 avis

Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective

Archive ouverte

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. Intravenously injected theranostic Gd-based nanoparticles enable targeting and MRI detection of brain metastases in patients.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

First-in-human trial of Gd-based theranostic nanoparticles: MRI assessment of uptake and biodistribution in patients with multiple brain metastases

Archive ouverte | Dufort, Sandrine | CCSD

International audience. We report here the main MRI findings of a dose escalation phase 1 clinical trial with intravenous administration of theranostic AGuIX nanoparticles, conducted in 15 patients with brain metast...

First-in-human trial of Gd-based theranostic nanoparticles: MRI assessment of uptake and biodistribution in patients with multiple brain metastases

Archive ouverte | Dufort, Sandrine | CCSD

First-in-human trial of Gd-based theranostic nanoparticles: MRI assessment of uptake and biodistribution in patients with multiple brain metastases

Archive ouverte | Dufort, Sandrine | CCSD

Chargement des enrichissements...